TOP1 and ovarian cancer: Colon cancer cells treated with high doses of DNA topoisomerase I inhibitor, SN-38 [4], and ovarian cancer cells exposed to poly(ADP-ribose) polymerase inhibitor, olaparib [20], behaved similarly.